NuScale Power Corporation stocks have been trading down by -5.79 percent amid heightened concerns over project financing and regulatory delays.
Live Update At 17:03:11 EDT: On Monday, May 18, 2026 NuScale Power Corporation stock [NYSE: SMR] is trending down by -5.79%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Quick Financial Overview
NuScale Power, trading under ticker SMR, is behaving like a classic story stock whose numbers haven’t caught up to the narrative. The latest quarterly filing shows just $565,000 in total revenue against $58.1M in expenses and a net loss of $44M. That is a tiny top line for a company valued at a steep price‑to‑sales ratio above 200.
SMR’s income statement is loaded with research and general and administrative costs, which is normal for an early‑stage technology story, but the losses are heavy. EBITDA came in around –$57.2M for the quarter, and operating cash flow was roughly –$314.7M. Free cash flow was about –$316.2M, so NuScale is burning cash fast.
On the plus side, SMR still shows a strong liquidity cushion. Cash and short‑term investments are close to $890M, with a current ratio around 4.3 and no meaningful long‑term debt. That buys NuScale time. But the return metrics are ugly, with return on equity and return on assets deeply negative, making this a high‑risk development‑stage nuclear play.
On the chart, SMR has broken down from the $13s in late April to about $10.48 on the latest close, with intraday action pinned in a tight $10.2–$10.6 band. That tells traders the stock is in a cooling phase, waiting for the next catalyst.
Why Traders Are Watching SMR Right Now
SMR is in the spotlight for all the wrong reasons, and that’s exactly why active traders are glued to it. The headline issue is the securities class action blasting NuScale Power over its relationship with ENTRA1 Energy. The complaint centers on a massive $495M payment tied to a TVA agreement that helped trigger a brutal $532M quarterly net loss and a plunge in SMR from above $57 to near $17 by 2025/11. That’s not a minor bump — it’s a full‑on reset of expectations.
Rosen Law Firm and Faruqi & Faruqi are both pushing class actions that argue NuScale misled the market about ENTRA1’s experience and the real risks inside its commercialization strategy. For traders, that goes beyond accounting noise. These lawsuits question whether SMR’s core deployment roadmap for its small modular reactors was sold as safer and more mature than it really was.
Another suit claims NuScale’s reliance on ENTRA1 exposed SMR to hidden risks of project failure, timetable delays, and regulatory problems. That kind of language hits the heart of any long‑dated clean‑energy story. If regulators or counterparties start doubting the plan, future cash flows get discounted hard.
Then there’s the Fluor angle. Fluor, once a key strategic backer, has fully exited its 40M‑share NuScale position via about $2.43B of open‑market sales since 2025/09. For SMR traders, that explains a lot of the persistent selling pressure. The flip side: with Fluor out, that big overhang is gone, and future supply from that seller is off the table.
Layer on top the Street’s fading confidence. Citi has slashed its SMR price target twice — first from $11.50 to $9, then down again to $7 — while sticking with a Sell rating and flagging a tough earnings backdrop for alt‑energy equipment names. Goldman Sachs trimmed its target from $10 to $9 and stayed Neutral, a quieter but still negative revision. When multiple firms walk targets lower like that, momentum traders listen.
All of this leaves SMR sitting in a high‑volatility zone where bad news is priced in, but sharp squeezes are always possible on any upside surprise.
More Breaking News
- BRC Stock Holds Steady As $1.4B Honeywell Deal Reshapes Growth Story
- ELAN Stock Dips As Traders Reassess Animal Health Play
- Workday Stock Rises As AI Integrations Deepen With Microsoft 365
- Redwire Stock Jumps As Price Targets And Backlog Surge
Conclusion
NuScale Power is exactly the kind of name that can reward prepared traders and punish lazy ones. The SMR story sits at the crossroads of ambitious nuclear tech, heavy cash burn, major legal battles, and wavering Wall Street support. The financials show a company with plenty of cash today but no clear line of sight yet to meaningful, recurring revenue. The lawsuits allege that SMR’s commercialization partner ENTRA1 was oversold and under‑disclosed, and that a $495M payment helped blow a gigantic hole in one quarter’s results.
At the same time, Fluor’s full exit and the series of price‑target cuts from Citi and Goldman frame SMR as a battleground ticker. Some traders will see a broken story; others will see a crowded short and a possible squeeze candidate if NuScale delivers any credible progress on deployments or regulatory wins.
The key is to treat SMR like the speculative trade it is. Size small, respect the volatility, and focus on the chart. As Tim Sykes loves to remind his students, “The market doesn’t care about your opinion, it cares about price action — adapt or you’re dead.” As millionaire penny stock trader and teacher Tim Sykes says, “Embrace the journey, the ups and downs; each mistake is a lesson to improve your strategy.” For educational and research‑focused traders, SMR is a live case study in how hype, legal risk, and real numbers collide.
This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.
Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:
- Penny Stocks Trading Guide
- Best Penny Stocks Under $1 to Buy Today
- Top 8 Penny Stocks to Watch on Robinhood
Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:
Leave a reply